Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline characteristics of a diagnostically defined early psychosis cohort entering supported employment and education: findings from the SEEearly trial.

European archives of psychiatry and clinical neuroscience·2026
Same author

Unravelling the Link Between Body Mass Index and Cognitive Performance in Individuals With Bipolar Disorder and Exploration of PRS Moderation Effect: Findings From the PsyCourse Study.

Acta psychiatrica Scandinavica·2025
Same author

PACIC: patient activation and problem solving not related to age in patients with depressive symptoms.

European archives of psychiatry and clinical neuroscience·2025
Same author

Der Nervenarzt·2025
Same author

Dissecting heterogeneity in cortical thickness abnormalities in major depressive disorder: a large-scale ENIGMA MDD normative modelling study.

bioRxiv : the preprint server for biology·2025
Same author

Suboptimal antidepressant use among inpatients and outpatients with symptoms of depression: a cross-sectional analysis of the POKAL core data set.

European archives of psychiatry and clinical neuroscience·2025

Related Experiment Video

Updated: Jun 27, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Neurocognitive functions in euthymic bipolar patients.

K Jamrozinski1, O Gruber, C Kemmer

  • 1Department of Psychiatry and Psychotherapy, Georg-August-University Goettingen, Goettingen, Germany.

Acta Psychiatrica Scandinavica
|December 17, 2008
PubMed
Summary
This summary is machine-generated.

Antipsychotic medications may impair cognitive functions in euthymic bipolar I disorder patients, affecting memory and executive functions. Further research is needed to clarify these medication side effects on neuropsychological test performance.

Related Experiment Videos

Last Updated: Jun 27, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Area of Science:

  • Neuroscience
  • Psychiatry

Background:

  • Bipolar disorder is associated with neurocognitive deficits.
  • Previous meta-analyses suggest impairments in attention, processing speed, memory, and executive functions.

Purpose of the Study:

  • To assess neurocognitive impairment in euthymic bipolar I disorder patients compared to healthy controls.
  • To investigate the impact of medication side-effects and illness characteristics on neuropsychological test performance.

Main Methods:

  • A cross-sectional study compared 40 euthymic bipolar I disorder patients with 40 healthy controls.
  • Neuropsychological tests assessed IQ, psychomotor speed, verbal fluency, memory, executive functions, and attention.

Main Results:

  • Patients not using antipsychotics showed no significant cognitive differences compared to controls.
  • Patients on antipsychotics exhibited significant underperformance in semantic fluency, verbal learning, recognition memory, and planning abilities.
  • These deficits persisted even after controlling for clinical features.

Conclusions:

  • Antipsychotic medication significantly impacts cognitive functions in euthymic bipolar patients.
  • Consideration of antipsychotic use is crucial when interpreting neuropsychological test results in this population.